David Endicott, Alcon CEO World Sight Day 2024 focuses on the importance of eye care in young people. As the CEO of the ...

DKSH Healthcare Business Unit, a leading partner for healthcare companies seeking to grow their business in Asia and beyond, is excited to announce a series of initiatives across Asia in observance of ...

Advancements and Projections in the Ophthalmic Devices Market: Insights, Trends, Opportunities, and Recent DevelopmentsNew ...

The first step to finding a better price for contact lenses is to find an affordable vision exam to get your prescription.

Alcon Inc. (NYSE:ALC), a global leader in eye care products, finds itself at a critical juncture as it navigates a competitive landscape while leveraging its robust product pipeline. The company ...

A potential sale of Bausch + Lomb presents a significant opportunity for Bausch Health. The deal could provide the company ...

Alcon Inc.’s ALC growth is driven by its robust ... Ocular Health continues to report strong performance with its portfolio of eye drops, including continued strength from the Systane family ...

This includes the novel 1-week contact lens Precision-7, the next version of PanOptix, and the potential FDA approval of AR-15512 for dry eye treatment. Alcon’s management expects these new ...

Alcon’s shares made their debut on the SIX Swiss Exchange this morning and rose quickly, with early trading valuing the now-independent specialist in contact lenses and other eye care devices at ...

Alcon said the Aerie deal is another example of its strategy to expand in the ophthalmic pharmaceutical eye drop space. "Aerie is a natural fit with on-market and pipeline products, and R&D ...